ZEMDRI

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Jun 25, 2018

   8 yr 1 mo ago

2. Exclusivity ends · NCE

   New chemical entity exclusivity (5 years)

   Jun 25, 2023

   3 yr ago

3. Today

4. Exclusivity ends · GAIN

   Qualified infectious disease product exclusivity (adds 5 years)

   Jun 25, 2028

   in 2 yr 1 mo

5. Patent 8822424 expires

   Listed drug product patent expiration.

   Nov 21, 2028

   in 2 yr 6 mo

6. Patent 9266919 expires

   Listed method-of-use patent (U-2328) expiration.

   Nov 21, 2028

   in 2 yr 6 mo

7. Patent 9688711 expires

   Listed drug substance patent expiration.

   Nov 21, 2028

   in 2 yr 6 mo

8. Patent 8383596 expires

   Listed drug substance patent expiration.

   Jun 25, 2032

   in 6 yr 1 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (2)

• NCENew chemical entity exclusivity (5 years)

  Jun 25, 2023

  3 yr ago

• GAINQualified infectious disease product exclusivity (adds 5 years)

  Jun 25, 2028

  in 2 yr 1 mo

Listed patents (4)